More of the same.
Psychopharmaceutical industry seeks world of dispassionate sheeple
People who obediently follow the herd, never markedly sad, angry or excited; children who play quietly and never annoy or talk out of turn – this is the object of the psychiatric/pharmaceutical industries. And when anyone steps out of line, the answer is simple: stamp them “abnormal” and give them a pill.
Human sorrow could soon be more easily diagnosed and medicated as a mental disorder. Psychiatrists creating the next edition of the psychiatric bible – the Diagnostic Statistical Manual (DSM-5, due out in 2013) – are recommending to eliminate the time clause for major depressive disorder. So instead of grieving for two months to qualify, if you mourn the loss of a loved one for only two weeks doctors could label you mentally ill and prescribe a drug.
The first DSM published in 1952 was a 132-page volume listing 128 mental disorders. With nearly 900 pages, the current edition (DSM-IV, published in 1994) lists 357 disorders – an over 300% increase. Since its release, DSM-IV has generated a 256% increase in psychiatric drug sales and billions of dollars in government funding.
Drug companies are notorious for downplaying disabling effects of psychotropic drugs. Additionally, medical journalist and Pulitzer Prize nominee Robert Whitaker reports that many psychiatric drug users acquire a more severe form of mental illness than they started with. For instance, antidepressant users tend to spiral down into long-term depression – yielding even greater profit for psychiatrists and drugmakers.